SWX:SGKN
SWX:SGKNBanks

Is There Still Opportunity in St. Galler Kantonalbank as Shares Rise 28% This Year?

Thinking about what to do with your St. Galler Kantonalbank shares, or maybe contemplating whether now is the right moment to jump in? You are not alone. This established Swiss bank has quietly rewarded patient investors, with the stock climbing nearly 28.3% over the past year and an impressive 55.6% over the last five years. Even in the short term, the stock posted a solid 2.0% gain this week, extending its steady 14.8% rise year-to-date. Recent price movements may reflect shifting market...
SWX:VONN
SWX:VONNCapital Markets

Does Recent Swiss Banking Volatility Offer an Opportunity in Vontobel Holding for 2025?

If you have been keeping an eye on Vontobel Holding, you are not alone. Investors and analysts alike are sizing up whether now is the right time to make a move on this financial stock. After climbing an impressive 14.1% over the past year, the stock has cooled off slightly in 2024, down 5.0% year-to-date. The past month has seen the price nudge down by 1.1%, though it has been steady over the last week with a 1.2% gain. This mix of short-term hesitation and long-term growth might seem...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Stock Surges 12.6% as Swiss Leaders Address US Pharma Tariff Concerns

Trying to decide what to do with Roche Holding stock right now? You're not alone. The last several weeks have seen Roche make some impressive moves, with shares up 12.6% in just the past seven days and 14.5% over the year. It's a bounce that has certainly caught the market's attention, especially when you compare it to the roughly flat performance over the last three years. There is clearly a new sense of optimism, or perhaps just a major shift in how investors are weighing the risks and...
SWX:BARN
SWX:BARNFood

Is Barry Callebaut’s Recent 5% Rally a Sign of a Turning Point in 2025?

If you’re watching Barry Callebaut’s stock and wondering whether now is the right time to act, you’re not alone. The company’s share price has had a bumpy ride lately, sparking plenty of chatter among market watchers and long-term investors alike. Over just the last week, the stock jumped 5.3%. If you zoom out, however, the bigger picture tells a more cautious tale: losses of 4.8% so far this year and a steep drop of 23.5% over the past twelve months. Even looking back five years, the shares...
SWX:PGHN
SWX:PGHNCapital Markets

What Do Recent Private Markets Shifts Mean for Partners Group Shareholders in 2025?

Are you sitting on the fence about what to do with Partners Group Holding stock? You are not alone. With shares at CHF 1057.5, recent market action has been a bag of mixed signals. The stock bounced up 2.0% in the past week, maybe reflecting some renewed optimism, but over the last month, it dipped by 1.0%, and the year-to-date story is even less cheerful, showing a 15.1% drop. While that might look concerning, it is important to zoom out. The 3-year and 5-year returns are still strongly...
SWX:NESN
SWX:NESNFood

Is Now the Right Moment for Nestlé After Its Recent 2.9% Share Price Rise?

If you’re wondering whether Nestlé’s stock deserves a spot in your portfolio right now, you’re definitely not alone. With a company as globally recognized as Nestlé, it’s tempting to expect smooth sailing, but recent performance has kept investors on their toes. Over the past week, the stock has quietly risen 2.9%, hinting at some renewed optimism in the market. Yet, zooming out tells a slightly different story: the one-year return sits at -8.1%, and over the past five years, shares are down...
SWX:CFR
SWX:CFRLuxury

Does Richemont’s Recent 18.9% Rally Signal Room for Further Growth in 2025?

If you are weighing your options with Compagnie Financière Richemont, you are not alone. This stock has steadily grabbed the market's attention, performing like a hidden gem that keeps rewarding patient investors. Over the past week alone, Richemont shares climbed 2.9%, and in the last month, they rallied 7.6%. Stretch that timeline further, and the impressive 15.9% gain year-to-date is matched by a striking 18.9% return over the last year. Looking even further back, the long-term gains stand...
SWX:ALC
SWX:ALCMedical Equipment

Alcon (SWX:ALC) Valuation: Is There Real Upside After Recent Modest Share Price Gain?

Alcon (SWX:ALC) shares drifted slightly higher today, rising a little over 2%. With solid annual revenue and net income growth, investors are watching how the market weighs these fundamentals after a few disappointing months for the stock. See our latest analysis for Alcon. This latest uptick is a welcome change for Alcon after a sluggish patch, though momentum has generally faded over recent months. Even with solid fundamentals, the stock’s share price return over the past year remains...
SWX:PPGN
SWX:PPGNLife Sciences

3 European Stocks Estimated To Be Up To 45.4% Below Intrinsic Value

As European markets reach record highs, buoyed by a rally in technology stocks and expectations for lower U.S. borrowing costs, investors are keenly exploring opportunities that may be undervalued amidst the broader economic optimism. In this environment, identifying stocks trading below their intrinsic value can offer potential advantages as market sentiment continues to shift.
SWX:KURN
SWX:KURNBiotechs

European Growth Stocks Insiders Are Eager To Own

As European markets reach record highs, driven by a rally in technology stocks and optimism around potential U.S. rate cuts, investors are increasingly focusing on growth opportunities within the region. In this favorable environment, companies with high insider ownership often stand out as promising candidates, signaling confidence from those who know the business best.
SWX:AMRZ
SWX:AMRZBasic Materials

Does the Recent Amrize Partnership Signal a New Opportunity for Investors in 2025?

Deciding what to do with Amrize at this moment can feel a bit like standing at a crossroads. Maybe you have watched the price tick up 2.4% over the last week and wondered if this is the start of a comeback. At the same time, the stock is still down 9.0% for the past 30 days and has lost 16.4% so far this year, reflecting the market’s uncertainty and shifting appetite for risk in this sector. Some recent developments in the broader market seem to have nudged investors’ perception of Amrize,...
SWX:SDZ
SWX:SDZPharmaceuticals

Assessing Sandoz Group (SWX:SDZ) Valuation After Delivering a 33% Total Return Over the Past Year

Sandoz Group (SWX:SDZ) has attracted investor attention recently, delivering steady total returns of 33% in the past year. The stock’s performance stands out in a challenging environment and prompts a closer look at what’s driving sentiment. See our latest analysis for Sandoz Group. Sandoz Group’s share price has advanced steadily this year, with positive momentum building on the back of a strong 1-year total shareholder return of 33%. Recent, smaller share price moves have been relatively...
SWX:LOGN
SWX:LOGNTech

Logitech (SWX:LOGN) Valuation: Is the Recent Share Price Momentum Justified?

Logitech International (SWX:LOGN) has seen its stock travel higher over the past month, climbing more than 5%. Investors are keeping an eye on how the company’s fundamentals stack up at current levels. See our latest analysis for Logitech International. Momentum has started to build for Logitech International as the share price has picked up in recent weeks, moving higher after a steady period earlier in the year. While this move adds to positive sentiment, it follows a year where the total...
SWX:NOVN
SWX:NOVNPharmaceuticals

Assessing Novartis (SWX:NOVN) Valuation After Steady Gains and Positive Financial Growth

Novartis (SWX:NOVN) shares have edged higher recently, gaining nearly 1% over the past month. Investors seem to be focusing on the company's steady financial performance, as both annual revenue and net income growth are trending positively. See our latest analysis for Novartis. Momentum for Novartis has been gradually building, with its share price holding firm at $105.22 and the 1-year total shareholder return sitting at over 11%. These steady gains suggest investors are seeing value in the...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Valuation in Focus After New Nottingham Facility Boosts Infrastructure Expansion

ABB (SWX:ABBN) has opened a major new manufacturing and research facility in Nottingham, U.K., focused on advanced earthing and lightning protection solutions. This move signals ABB’s commitment to infrastructure safety, research, and expanding global capacity. See our latest analysis for ABB. ABB’s unveiling of its new Nottingham facility comes amid a steady climb in total shareholder returns, with a 1-year TSR of 21.6% and an impressive 85.9% over the past five years. Strong sector...